Percutaneous Release vs Steroid Injection for Trigger Finger
- Disease/Condition
- Trigger Finger
- Drug/Device/Intervention
- Percutaneous release
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Armed Police Force Hospital, Nepal
- Location
- Kathmandu, Nepal
- Phase
- N/A
- Start date
- Jun 01, 2022
- End date
- Nov 01, 2022
- Enrollment
- 112 participants
Functional mobility improvement,Pain reduction
Trigger fingers (TF) is the common cause of pain and disturbed function of hand. Many studies
 show that percutaneous release of A1 pulley has better outcome than the steroid injection.
 However, over the past many years, steroid injection has been considered as the choice of
 treatment after the failure of conservative treatment methods. The aim of this study is to
 assess the effect of percutaneous release of A1 pulley compared with the local Steroid
 injection in the treatment of trigger fingers.
 
 This study is based on a randomized clinical trial to compare the effect of the percutaneous
 release of A1 pulley with steroid injection in trigger fingers. A total of 112 participants
 aged 18 years and above suffering from trigger fingers with failed conservative treatment
 will be intervened randomly (56 participants in injection group and 56 participants in
 percutaneous release group). The Quinnell's classification, VAS scoring system and active
 range of movement in the affected site will be assessed at the baseline and the same criteria
 will be at one month and three month as end line assessment. Statistical analyses will be
 performed using independent t-test and Mann Whitney U test to compare between the two means.
 The outcome of this study will help to guide the physicians to choose the better therapeutic
 approach among the patients suffering from trigger fingers.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05383040
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05383040 through Pure Global AI's free database. This phase not specified trial is sponsored by Armed Police Force Hospital, Nepal and is currently Not yet recruiting. The study focuses on Trigger Finger. Target enrollment is 112 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.